APA
Nafee T., Gibson C. M., Yee M. K., Alkhalfan F., Chi G., Travis R., Mir M., Kalayci A., Jafarizade M., Ganti A., Kazmi S. H., Ghaffarpasand E., Pitliya A., Datta S., Sharfaei S., Alihashemi M., Elsaiey A., Qamar I., Jahansouz M., Talib U., Kahe F., Habibi S., Abdelwahed M., Tariq F., Kaur M., Younes A., Walia S. S., Singh A., Dildar S. M., Afzal M. K. & Kerneis M. (20181211). Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism. : Expert review of cardiovascular therapy.
Chicago
Nafee Tarek, Gibson C Michael, Yee Megan K, Alkhalfan Fahad, Chi Gerald, Travis Ryan, Mir Mahshid, Kalayci Arzu, Jafarizade Mehrian, Ganti Aditya, Kazmi Syed Hassan, Ghaffarpasand Eiman, Pitliya Anmol, Datta Sudarshana, Sharfaei Sadaf, Alihashemi Mahda, Elsaiey Ahmed, Qamar Iqra, Jahansouz Mohamadmostafa, Talib Usama, Kahe Farima, Habibi Shaghayegh, Abdelwahed Mohammed, Tariq Feham, Kaur Manpreet, Younes Ahmed, Walia Sargun S, Singh Amandeep, Dildar Syed Muhammad, Afzal M Khurram and Kerneis Mathieu. 20181211. Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism. : Expert review of cardiovascular therapy.
Harvard
Nafee T., Gibson C. M., Yee M. K., Alkhalfan F., Chi G., Travis R., Mir M., Kalayci A., Jafarizade M., Ganti A., Kazmi S. H., Ghaffarpasand E., Pitliya A., Datta S., Sharfaei S., Alihashemi M., Elsaiey A., Qamar I., Jahansouz M., Talib U., Kahe F., Habibi S., Abdelwahed M., Tariq F., Kaur M., Younes A., Walia S. S., Singh A., Dildar S. M., Afzal M. K. and Kerneis M. (20181211). Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism. : Expert review of cardiovascular therapy.
MLA
Nafee Tarek, Gibson C Michael, Yee Megan K, Alkhalfan Fahad, Chi Gerald, Travis Ryan, Mir Mahshid, Kalayci Arzu, Jafarizade Mehrian, Ganti Aditya, Kazmi Syed Hassan, Ghaffarpasand Eiman, Pitliya Anmol, Datta Sudarshana, Sharfaei Sadaf, Alihashemi Mahda, Elsaiey Ahmed, Qamar Iqra, Jahansouz Mohamadmostafa, Talib Usama, Kahe Farima, Habibi Shaghayegh, Abdelwahed Mohammed, Tariq Feham, Kaur Manpreet, Younes Ahmed, Walia Sargun S, Singh Amandeep, Dildar Syed Muhammad, Afzal M Khurram and Kerneis Mathieu. Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism. : Expert review of cardiovascular therapy. 20181211.